Higher denial of drug problems was associated with poorer cognitive performance in a study of methamphetamine-dependent adults. That finding supports investigating insight; it does not establish that a particular person is lying, lacks capacity, or cannot understand consequences.
Dean and colleagues studied 58 adults who were not seeking treatment. Participants completed a cognitive battery and the URICA Precontemplation scale, which measures attitudes toward recognizing a drug problem and changing behavior. Twenty-one also underwent resting-state functional MRI. This was a human observational study, with no experimental methamphetamine administration.
Higher Precontemplation scores were associated with lower overall cognition (p = 0.001), particularly learning and memory and executive functioning. The processing-speed/attention relationship did not reach conventional statistical significance (p = 0.094); working memory was also nonsignificant (p = 0.404), with fewer participants available for that domain. The study therefore did not show a uniform relationship across every cognitive ability.
Denial scores were negatively associated with selected connections involving the rostral anterior cingulate and precuneus. Anterior insula connectivity was not significantly associated with denial. Several relationships weakened when the researchers adjusted for years of methamphetamine use, showing that exposure history and the proposed insight-related phenotype were not cleanly separable.
A questionnaire score and a brain-network correlation are not independent proof that someone knowingly made a false statement. The design cannot determine whether cognitive differences preceded drug use, followed it, or share another cause. The imaging subgroup was small, and associations within a selected research sample require replication. In an individual assessment, the relevant evidence remains the person’s actual statements, understanding, behavior and circumstances; this study supplies context rather than a credibility verdict.
For a separate question, see self-reported executive difficulties during recovery.
Read the original study (DOI: 10.1016/j.drugalcdep.2015.03.004).